Last reviewed · How we verify
GDC-6988
At a glance
| Generic name | GDC-6988 |
|---|---|
| Also known as | RO7506811 |
| Sponsor | Genentech, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- GDC-6988 CI brief — competitive landscape report
- GDC-6988 updates RSS · CI watch RSS
- Genentech, Inc. portfolio CI